ASX:COHMedical Equipment
What Cochlear (ASX:COH)'s FDA Approval for Upgradeable Nucleus Nexa System Means For Shareholders
Cochlear Limited recently received U.S. FDA approval for its Nucleus Nexa System, the first smart cochlear implant featuring upgradeable firmware in both the implant and sound processor.
This technological milestone enables recipients to benefit from future innovations without having to replace core components, potentially enhancing the long-term user experience.
We'll explore how this breakthrough, bringing firmware upgrade capability to cochlear implants, influences Cochlear's broader...